WednesdayNov 11, 2020 1:02 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Awarded First US Patent for Revolutionary UST(TM) Platform

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of pressure-based instruments, consumables and platform solutions to the worldwide life sciences and other industries, today announced the award of the first U.S. patent for its revolutionary Ultra Shear Technology(TM) (UST(TM)) platform. The patent, entitled "System for High Pressure, High Shear Processing of Fluids," brings the company's intellectual property ("IP") estate to a total of 26 issued patents. “Nanoemulsions have long been shown to exhibit improved absorption, higher bioavailability and greater stability, while often requiring lower levels of emulsifiers than macro/micro emulsion products,” said Dr. Edmund Y. Ting, Sr.,…

Continue Reading

WednesdayNov 11, 2020 1:00 pm

QualityStocksNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Announces Plan to Acquire Leading Automation Solution Provider

iClick Interactive (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, has entered into an agreement to acquire the entire issued share capital of CMRS Group Holding Limited ("CMRS"). CMRS, a leading marketing automation solution provider based in Hong Kong, owns proprietary technology designed to aggregate data from multiple sources to help companies offer improved customer relationship management (“CRM”) services. Through the planned acquisition, iClick anticipates being able to enhance its already full product offerings, specifically for cross-border customers marketing into China. In addition, iClick expects that CMRS's proven profitability, resources and potential to cross-sell iClick products will…

Continue Reading

WednesdayNov 11, 2020 12:15 pm

QualityStocksNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Leveraging Patented Science to Create Unique Products

Kaival Brands (OTCQB: KAVL), a company focused on developing products into mature, dominant brands, has turned its attention to a new space through acquisition of a patent covering the creation of all synthetic nicotine smoking cessation and synthetic nicotine addiction therapy products. The company’s newly created and wholly owned subsidiary — Kaival Labs — will own the patent and develop associated products. “The science behind these patents has discovered that within the nicotine molecule, the S-isomers control the addictive properties, whereas the R-isomers control the beneficial qualities of the nicotine that a user enjoys,” said Kaival Brands CEO Niraj Patel.…

Continue Reading

WednesdayNov 11, 2020 12:13 pm

QualityStocksNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Announces Q3 Financials, New Leadership Appointment

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) has released its Q3 2020 financial results. In addition, the company announced a leadership change and provided business highlights for the third quarter ending September 30, 2020. TGOD saw total revenues for Q3 2020 total $5.7 million, which represents a 119% increase over the same quarter last year. Of that, $3.84 million was categorized as Canadian cannabis revenue, and increase of 41% quarter over quarter. In addition, loss from operations and G&A expenses were both down significantly. The company also announced two leadership changes: chief financial officer Sean Bovingdon will be serving as interim…

Continue Reading

WednesdayNov 11, 2020 11:50 am

QualityStocksNewsBreaks – Hemptown Organics Corp. Featured in ‘America’s Next Investment’

Hemptown Organics, an industry leading cannabinoid company delivering a diverse product offering, was recently featured in “America's Next Investment” — a national TV series focused to help companies raise capital through equity crowdfunding. The episode focused on Hemptown’s regulation D offering, highlighting a promising investment opportunity in the hemp industry, with the U.S. market expected to hit $16 billion by 2025. “In the 90s, we didn’t have hemp, we didn’t have CBD,” Hemptown Founder Rod Wolterman said regarding the company’s entry into the sector. “We’ve figured out that we have endocannabinoid systems. We produce CB1 and CB2 in our bodies.…

Continue Reading

WednesdayNov 11, 2020 11:21 am

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Participate in Life Sciences Summit Panel

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its senior vice president of intellectual property and licensing, Thomas Gallagher, will participate at the annual NYC-based Life Sciences Summit. Gallagher will take part in a panel discussion titled, “Show Me the Money: Preparing Your Company for Funding,” at the event, slated to place virtually November 17-18, 2020. During the panel discussion, scheduled for 10-10:45 a.m. ET on Tuesday, November 17, experts will provide insight into the essential building blocks needed for emerging companies to reach their goals.…

Continue Reading

WednesdayNov 11, 2020 10:49 am

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) to Discuss Q3 Financials During Nov. 16 Call

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies, has announced an upcoming conference call. During the call, SRAX management will discuss the company’s Q3 financial report. The call is scheduled for Nov. 16, 2020, at 9 a.m. PT. SRAX founder and CEO Christopher Miglino and SRAX CFO Michael Malone will lead the call, which will provide an operational and financial summary of SRAX’s 2020 third-quarter numbers. Anyone interested in the presentation should register early to participate in the presentation; the live call can also be accessed by dialing  1-669-900-6833 and using the…

Continue Reading

WednesdayNov 11, 2020 10:21 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) Goes Public on Canada’s Next-Gen Stock Exchange

Cybin (NEO: CYBN), a leading Toronto-based biotech and life sciences company focused on psychedelic pharmaceutical therapies, today made its debut on the global public markets and is now trading on the NEO Exchange under the symbol “CYBN.” The company, which focuses on psychedelic drug development, unique delivery mechanisms, improved novel compounds and protocols, recently closed a C$45 million subscription receipt financing in relation to its reverse takeover transaction. This signified the largest subscription receipt financing in the Canadian psychedelic sector. “Today marks a meaningful milestone for our company, as our shares begin trading on the NEO Exchange under the ticker…

Continue Reading

WednesdayNov 11, 2020 9:19 am

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Announces Plans to Present at Virtual Fall Investor Summit

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced that management will present at the Virtual Fall Investor Summit, hosted by Investor Summit Group and taking place November 16-18, 2020. According to the update, Trxade CEO Suren Ajjarapu is scheduled to participate in one-on-one meetings throughout the event and will host a virtual presentation at 2:30 p.m. Eastern Time (11:30 p.m. Pacific Time) on Tuesday, November 17, 2020. Interested parties may visit https://ibn.fm/gf2UL to register for the event and access the live webcast and archive of the presentation. To view the full press release, visit…

Continue Reading

TuesdayNov 10, 2020 2:40 pm

QualityStocksNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Announces Completion of Strategic Merger

180 Life Sciences (NASDAQ: ATNF, ATNFW), a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced the successful closing of its transaction with KBL Merger Corp IV. Prior to the merger’s closing, KBL Merger Corp. changed its name to 180 Life Sciences Corp., and 180 Life Sciences Corp. changed its name to 180 Life Corp., which now operates as a wholly owned subsidiary of the company. As a result of the merger, the units and rights of KBL Merger Corp. ceased trading, and the shares of its…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered